Gene · 2222
Papers2,006
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,006
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aggregation-prone A53T mutant of α-synuclein exaggerates methamphetamine neurotoxicity in SH-SY5Y cells: Protective role of cellular cholesterol. | Toxicol Rep | 2022 | 36518421 | PubTator, text mining | PubMed |
| Adjuvants in fungicide formulations can be skin sensitizers and cause different types of cell stress responses. | Toxicol Rep | 2022 | 36518395 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma. | Front Endocrinol (Lausanne) | 2022 | 36518255 | PubTator, text mining | PubMed |
| Placental macrophage responses to viral and bacterial ligands and the influence of fetal sex. | iScience | 2022 | 36505933 | PubTator, text mining | PubMed |
| Exploring differentially expressed genes related to metabolism by RNA-Seq in porcine embryonic fibroblast after insulin treatment. | J Vet Sci | 2022 | 36448436 | PubTator, text mining | PubMed |
| Integrative Analysis of Transcriptomic and Metabolomic Data for Identification of Pathways Related to Matrine-Induced Hepatotoxicity. | Chem Res Toxicol | 2022 | 36440846 | PubTator, text mining | PubMed |
| Scalable Generation of Nanovesicles from Human-Induced Pluripotent Stem Cells for Cardiac Repair. | Int J Mol Sci | 2022 | 36430812 | PubTator, text mining | PubMed |
| Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy. | Cancers (Basel) | 2022 | 36428613 | PubTator, text mining | PubMed |
| A review: extraction, phytochemicals, and biological activities of rambutan (Nephelium lappaceum L) peel extract. | Heliyon | 2022 | 36387459 | PubTator, text mining | PubMed |
| New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. | Acta Pharm Sin B | 2022 | 36386472 | PubTator, text mining | PubMed |
| APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. | Nature | 2022 | 36385529 | PubTator, text mining | PubMed |
| Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: Insights and future perspectives. | Asian J Pharm Sci | 2022 | 36382305 | PubTator, text mining | PubMed |
| Biotechnological Intervention and Secondary Metabolite Production in Centella asiatica L. | Plants (Basel) | 2022 | 36365380 | PubTator, text mining | PubMed |
| Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review. | Molecules | 2022 | 36364033 | PubTator, text mining | PubMed |
| Biological Properties of Latex, Aqueous Extracts and Bee Products of Euphorbia officinarum L.: A Short Review. | Molecules | 2022 | 36364025 | PubTator, text mining | PubMed |
| Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells. | Cancers (Basel) | 2022 | 36358633 | PubTator, text mining | PubMed |
| Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis. | Cell Death Discov | 2022 | 36357379 | PubTator, text mining | PubMed |
| Expression of PCOS candidate genes in bovine fetal and adult ovarian somatic cells. | Reprod Fertil | 2022 | 36346793 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| Fuzzy optimization for identifying anti-cancer targets with few side effects in constraint-based models of head and neck cancer. | R Soc Open Sci | 2022 | 36303939 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2222/papers?page=20